Really excited about this new initiative. Please help us spread the word to qualified applicants.

Thank you Amy Feldman for this thoughtful coverage of our portfolio company Tasso, Inc., bringing blood testing into the home to improve access to care.

Proud to be working with Pardes Biosciences -- with FSII we are working to combat COVID-19 via an oral medicine that, if approved by regulatory authorities, could be used to treat and prevent the disease. businesswire.com/news/home/2021… foresitecapital.com/legal-disclaim…

Great news out of Eikon Therapeutics yesterday, closing this round to help fuel their plans to analyze single molecule protein behavior in living cells. Their innovative tools and technologies for biological exploration will be used for drug discovery and beyond.

I'm very excited to announce the Tananbaum Center for Theoretical and Analytical Human Biology at Yale University led by Ruslan Medzhitov to uncover fundamental knowledge about disease. Read about our new center here: forhumanity.yale.edu/news/new-parad…

Welcoming ImmPACT Bio to our portfolio! Early clinical data is very promising in our view. We believe the efficacy & safety profile of the lead program will help expand access of CAR-T cell therapy to patients who have exhausted other options. Excited to work with this team!

Congratulations to the newest Foresite Labs incubated company, TenSixteen Bio , for launching today! The company is the first to leverage CHIP to uncover the mysterious mutations in the blood and how they impact disease. Read more via Endpoints News here: tinyurl.com/4njyfcvu

This is a stellar group, and I'm proud that my firm is providing full scholarships to the life sciences track for these future leaders in our industry. Thank you to Venture Forward and the NVCA.

I'm excited to support the team at Element Biosciences as they unveil their benchtop sequencer AVITI. I believe sequencing will touch all our lives. To enable it, we need high quality, inexpensive sequencing.

I'm proud to be supporting healthcare visionaries like Aaron.

Our managing director Michael Rome shares his thoughts on the Affinivax acquisition by GSK in our latest blog post: foresitecapital.com/blog/thoughts-…

I'm proud to work with this team. Read our latest blog post from managing director Michael Rome.

Congratulations to the scholarship recipients of Cohort 11 for the Venture Forward life sciences track of #VCUniversity! We are so proud of our work with this program. These people are the future of the life science VC industry, and I can't wait to see what they accomplish.

Please join my firm Foresite Capital in supporting this valuable program by volunteering as a life sciences peer mentor. The deadline is Friday.

It was an honor to welcome attendees on Saturday at Yale's for Humanity Illuminated event at the Yerba Buena Center. So proud to partner with this team. The Yale University community is incredibly special, and it was an inspirational day.

Congratulations to the team at Evonetix on this new funding round! We were excited to lead this investment to accelerate the company's commercial strategy and make gene synthesis more accessible.

I'm thrilled to have joined the LACMA board to help foster appreciation for culture and creativity in Los Angeles and beyond. Read my thoughts here: medium.com/@Jim-Tananbaum…

Great news for the team at XinThera with their acquisition by Gilead Sciences announced today. Foresite Capital was the founding investor. Read my colleague's thoughts here: foresitecapital.com/blog/xinthera-…

A new cohort of #VCUniversity starts tomorrow through Venture Forward, with this amazing group of scholarship recipients in the life sciences track who will be reshaping our industry in years to come. My firm Foresite Capital is proud to continue our support of this program.

Thank you to FierceBiotech for their coverage of our new fund, announced today. It's an exciting time to be a biotech investor, and we look forward to continuing our support of the entrepreneurs who are making a difference. fiercebiotech.com/biotech/foresi…